Stefano Bonini
Prof. Ordinario
Biografia
STEFANO BONINI Roma 10 Aprile 1953
Via Cassia Antica 35 00191 ROMA
Curriculum
2002-2013 Professore Ordinario di Oftalmologia e Direttore Scuola di Specializzazione in Oftalmologia Univ. di Roma Campus BioMedico Via Alvaro del Portillo 200 00155 ROMA
2002-03-2013Oculista incaricato presso la Santa Sede,Città del Vaticano; Adjunct Senior Scientist at the Schepens Eye Institute and Harvard Medical School Boston
2002-2013 Professore Ordinario di Oftalmologia e Direttore Scuola di Specializzazione in Oftalmologia Univ. di Roma Campus BioMedico Via Alvaro del Portillo 200 00155 ROMA2002-03-2013Oculista incaricato presso la Santa Sede, Città del Vaticano; Adjunct Senior Scientist at the Schepens Eye Institute and HarvardMedical School,Boston
Incarico di insegnamento: 1992-00Patologia Oculare - Oftalmologia pediatrica-Neurooftalmologia,Scuola di Specializzazione in Oftalmologia Univ.Tor VergataRoma,
Neurooftalmologia Scuola speciale Ortottisti e assistenti di Oftalmologia1990-00 Microbiologia ed Igiene Oculare Scuola di Specializzazione in Oftalmologia Univdi Tor Vergata Roma
1999 Professore Associato, Univ.Tor Vergata Roma Cattedra di Clinica Oculistica 1987 Ricercatore Confermato Univ. Roma Tor Vergata Cattedra Clinica Oculistica 1984 Ricercatore della Cattedra Clinica Oculistica Univ di Roma Tor Vergata 1977-84 Medico interno I Clinica Oculistica Univdi Roma "La Sapienza"1971Diploma di Maturità classica, Istituto Marcantonio Colonna, Roma1977 Laurea in Medicina e Chirurgia, Facoltà di Medicina e Chirurgia Univ. La Sapienza Roma (110/110 e lode) 1981Diploma di specializzazione in Oftalmologia Scuola di Specializzazione in Oftalmologia La Sapienza Roma (70/70 e lode)1989Diploma di specializzazione in Allergologia ed Immunologia Clinica, Scuola di Specializzazione in Allergologia ed Immunologia Clinica, Univ. La Sapienza Roma 1985-87 Fellowship presso l' Harvard Medical School,Boston, Massachusetts, USA, Eye Research Institute of Retina Foundation. Department of Immunology-CorneaUnit.
PUBBLICAZIONI
2012Lambiase A,ALOE L,MANTELLI F,Sacchetti M,PERRELLA E, BIANCHI P,ROCCO M,L,Bonini S APSAICIN-INDUCED CORNEAL SENSORY DENERVATION AND HEALING IMPAIRMENT ARE REVERSED BY NGF TREATMENT.INVESTIG OPHTHALMOLOGY &VISUAL SCIENCE, vol.53-Lambiase A,Sacchetti M,BoniniSNerve growth factor therapy for corneal disease.CURRENT OPINION IN OPHTHALMOLOGY,vol. 23,p. 296-302-Mantelli F,Lambiase A,Di Zazzo A,Bonini S Sands of sahara after LASIK in avellino corneal dystrophy.CASE REPORTS IN OPHTHALMOLOGY
2011Lambiase A,Leonardi A,Sacchetti M,Deligianni V, Sposato S,Bonini S.Topical cyclosporine prevents seasonal recurrences of vernal keratoconjunctivitis in a randomized, double-masked,controlled 2-year study.JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY,vol.128p.896-897-Lambiase A,Micera A,Sacchetti M,Cortes M,Mantelli F,Bonini S.BONINI S Alterations of tear neuromediators in dry eye disease.ARCHIVES OF OPHTHALMOLOGY,vol129p.981-986-Lambiase A,Mantelli F,Sacchetti M Rossi S Aloe L,Bonini S.BONINI S Clinical applications of NGF in ocular diseases.ARCHIVES ITALIENNES DE BIOLOGIE,vol.149-SACCHETTI M,MICERA A, LAMBIASE A,SPERANZA S,MANTELLI F,PETRACHI G,BONINI S, BONINI STear levels of neuropeptides increase after specific allergen challenge in allergic conjunctivitis. MOLECULAR VISION vol.17,p.47-52-Lambiase A,Micera A, Sacchetti M,Mantelli F,Bonini S.Toll-like receptors in ocular surface diseases:overview and new findings.CLINICAL SCIENCEvol120, p441-450-2010LAMBIASE A, MANTELLI F, BONINI SNerve growth factor eye drops to treat glaucoma. DRUG NEWS & PERSPECTIVES, vol23, p.361-367-MANTELLI F,MICERA A, SACCHETTI M,BONINI S.Neurogenic inflammation of the ocular surface. CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY,vol.10(5)p.498-504-SACCHETTI M,LAMBIASE A, MANTELLI F,DELIGIANNI V,LEONARDI A,BONINI S.Tailored approach to the treatment of vernal keratoconjunctivitis. EXCERPTA MEDICA. SECTION 12. OPHTHALMOLOGY, vol.117,p.1294-1299-2009 MANTELLI F,LAMBIASE A,BONINIS.A simple and rapid diagnostic algorithm for the detection of ocular allergic diseases.URRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, vol.9,p.471-476-LAMBIASE A,ALOE L,CENTFANTI M,PARISI V, MANTELLI F,COLAFRANCESCO V,MANNI GL,BUCCI MG,BONINI S,LEVI-MONTALCINI R.Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucomPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol.106(32), p.13469-13474-IOVIENO A,LAMBIASE A,MICERA A, STAMPACHIACCHIERE B,SGRULLETTA R BONINI S. In vivo characterization of doxycycline effects on tear metalloproteinases in patients with chronic blepharitis. EUROPEAN JOURNAL OF OPHTHALMOLOGY, vol.19,p.708-716-LAMBIASE A, MICERA A, BONINI S.Multiple action agents and the eye: do they really stabilize mast cells?CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, vol9p.454-465MICERA A, STAMPACHIACCHIERE B,NORMANDO EM,LAMBIASE A, BONINI S,BONINI SNerve growth factor modulates toll-like receptor (TLR)4 and 9 expression in cultured primary VKC conjunctival epithelial cells. MOLECULAR VISION, vol. 15, p. 2037-2044